| Age in years mean (range) |
63.8 ± 19 |
| Sex |
Male 78 (36% ) |
Female 139 (64%) |
| Admission Status
Inpatient
Outpatient |
No |
% |
183
34 |
84.3%
15.7% |
| Renal functions status
Stable "Normal Laboratory Findings"
Unstable " Marked abnormal Laboratory Findings" |
169
48 |
77.9%
23.1% |
| Liver functions status
Stable "Normal Laboratory Findings"
Unstable " Marked abnormal Laboratory Findings" |
191
26 |
88%
12% |
| Potassium level
Normal Level (3.5-5.5 mEq)
Hypokalaemia (<3.5 mEq)
Hyperkalaemia (>5.5 mEq) |
191
22
4 |
88%
10.2%
1.8% |
| Indication for digoxin: n (%) |
| |
Heart failure |
51 (23.5%) |
| |
Both Atrial Fibrillation and Heart Failure |
151 (69.6%) |
| |
Others e.g. Myocardial Infarction, Ventricular Septal Defet Complication, Other types of cardiac arrhythmia |
15 (6.9%) |
Digoxin Dosage: mg/day Mean (range) 0.17 ( 0.01 – 0.625 |
| Time of Sample: |
| |
At 2 hrs |
3 (1.4%) |
| |
At 4 hours |
6 (2.8%) |
| |
At 6 hours |
200 (92.1%) |
| |
At 8 hours |
6 (2.8%) |
| |
At 10 hours |
2 (0.9%) |
| Route of administration: |
| |
Oral |
194 (89.4%) |
| |
IV |
23 (10.6%) |
